Editing GSK plc (section)

===Market manipulation in the UK===
In February 2016, the company was fined over £37{{nbsp}}million in the UK by the [[Competition and Markets Authority]] for paying Generics UK, [[Alpharma]] and [[Norton Healthcare]] more than £50m between 2001, and 2004, to keep generic varieties of [[paroxetine]] out of the UK market. The generics companies were fined a further £8{{nbsp}}million. At the end of 2003, when generics became available in the UK, the price of paroxetine dropped by 70 per cent.<ref>{{cite news |title=Watchdog fines GSK £37m for paying to keep generic drugs out of UK market |last=Bradshaw |first=Julia |url=https://www.telegraph.co.uk/finance/newsbysector/pharmaceuticalsandchemicals/12153450/Watchdog-fines-GSK-37m-for-paying-to-keep-generic-drugs-out-of-UK-market.html |archive-url=https://ghostarchive.org/archive/20220111/https://www.telegraph.co.uk/finance/newsbysector/pharmaceuticalsandchemicals/12153450/Watchdog-fines-GSK-37m-for-paying-to-keep-generic-drugs-out-of-UK-market.html |archive-date=11 January 2022 |url-access=subscription |url-status=live |work=The Daily Telegraph |date=12 February 2016}}{{cbignore}}</ref>